Bar Cohen

Ms. Bar Cohen


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2022 in JMIR Formative Research
Verified
Journal Article
Open access
ASAriel Pollock Star
Ariel Pollock Star
YBYaacov Bachner
Yaacov Bachner
BCBar Cohen
Bar Cohen
OHOphir Haglili
Ophir Haglili
Norm O'RourkeNorm O'Rourke
Norm O'Rourke
Background: Reliable and consistent social support is associated with the mental health and well-being of persons with severe mental illness, including bipolar disorder (BD). Yet the COVID-19 pandemic and associated social distancing measures (eg, shelter in place) reduced access to regular social contacts, while social media use (SMU) increased concomitantly. Little is currently known about associations between the well-being of adults with BD and different types of SMU (eg, passive and active). Objective: For this study, we had two goals. First, we report descriptive information regarding SMU by persons with BD during COVID-19 (all platforms). Specific to Facebook, we next developed and tested a hypothesized model to identify direct and indirect associations between BD symptoms, social support, loneliness, life satisfaction, and SMU. Responses were collected during the global spread of the Delta variant and prior/concurrent with the Omicron variant, 20 months after the World Health Organization declared COVID-19 a global pandemic. Methods: Over 8 weeks, we obtained responses from an international sample of 102 adults with BD using the Qualtrics online platform. Most had previously participated in the BADAS (Bipolar Affective Disorders and older Adults) Study (n=89, 87.3%); the remainder were recruited specifically for this research (n=13, 2.7%). The subsamples did not differ in age (t100=1.64; P=.10), gender (χ22=0.2; P=.90), socioeconomic status (χ26=9.9; P=.13), or time since BD diagnosis (t97=1.27; P=.21). Both were recruited using social media advertising micro-targeted to adults with BD. On average, participants were 53.96 (SD 13.22, range 20-77) years of age, they had completed 15.4 (SD 4.28) years of education, and were diagnosed with BD 19.6 (SD 10.31) years ago. Path analyses were performed to develop and test our hypothesized model. Results: Almost all participants (n=95, 93.1%) reported having both Facebook and LinkedIn accounts; 91.2% (n=93) reported regular use of either or both. During the pandemic, most (n=62, 60.8%) reported accessing social media several times a day; 36.3% (n=37) reported using social media more often since the emergence of COVID-19. Specific to Facebook, the model we hypothesized differed somewhat from what emerged. The resulting model suggests that symptoms of depression predict loneliness and, inversely, social support and life satisfaction. Social support predicts social Facebook use, whereas passive Facebook use predicts life satisfaction. Symptoms of depression emerged as indirect predictors of SMU via social support. Conclusions: Our findings suggest that the operational definition of passive-active SMU requires further analysis and refinement. In contrast to theory, passive Facebook use appears positively associated with well-being among certain populations. Longitudinal data collection over multiple points is required to identify associations between BD symptoms, SMU, and well-being over time.

7 February 2023 in JMIR Formative Research
Verified
Journal Article
Open access
BCBar Cohen
Bar Cohen
ASAndrew Sixsmith
Andrew Sixsmith
ASAriel Pollock Star
Ariel Pollock Star
OHOphir Haglili
Ophir Haglili
Norm O'RourkeNorm O'Rourke
Norm O'Rourke
Background: Despite the efficacy of treatment and severity of symptoms, medication adherence by many with bipolar disorder (BD) is variable at best. This poses a significant challenge for BD care management. Objective: For this study, we set out to identify psychosocial and psychiatric predictors of medication adherence with BD. Methods: Using microtargeted social media advertising, we recruited an international sample of young and older adults with BD living in North America (Canada and the United States), Western Europe (eg, United Kingdom and Ireland), Australia and New Zealand (N=92). On average, participants were 55.35 (SD 9.65; range 22-73) years of age, had been diagnosed with BD 14.25 (SD 11.14; range 1-46) years ago, and were currently prescribed 2.40 (SD 1.28; range 0-6) psychotropic medications. Participants completed questionnaires online including the Morisky Medication Adherence Scale. Results: Medication adherence did not significantly differ across BD subtypes, country of residence, or prescription of lithium versus other mood stabilizers (eg, anticonvulsants). Path analyses indicate that alcohol misuse and subjective or perceived cognitive failures are direct predictors of medication adherence. BD symptoms, psychological well-being, and the number of comorbid psychiatric conditions emerged as indirect predictors of medication adherence via perceived cognitive failures. Conclusions: Alcohol misuse did not predict perceived cognitive failures. Nor did age predict medication adherence or cognitive failures. This is noteworthy given the 51-year age range of participants. That is, persons in their 20s with BD reported similar levels of medication adherence and perceived cognitive failures as those in their 60s. This suggests that perceived cognitive loss is a facet of adult life with BD, in contrast to the assumption that accelerated cognitive aging with BD begins in midlife.

20 November 2024 in BMJ Open
Verified
Journal Article
Open access
PDF file
IYIlan Yehoshua
Ilan Yehoshua
SGSharon Baruch Gez
Sharon Baruch Gez
BCBar Cohen
Bar Cohen
BHBeatriz Hemo
Beatriz Hemo
AIAngela Irony
Angela Irony
LALimor Adler
Limor Adler
Objectives This study aims to evaluate and compare health outcomes and costs between home hospitalisation and traditional hospitalisation for three common diagnoses—cellulitis, urinary tract infection (UTI) and pneumonia. Design A retrospective cohort study. Setting Primary care, nationwide. Participants 1311 patients in home hospitalisation and 992 in traditional hospitalisation. Interventions The primary intervention is home hospitalisation, compared with traditional hospitalisation. The intervention was performed according to medical considerations by a specialised team, and this study was done retrospectively to evaluate it. Primary and secondary outcome measures Primary measures included healthcare costs, length of hospitalisation, referrals for further medical services and mortality. Results Costs of home hospitalisation were lower compared with traditional hospitalisation (6056 vs 9619 NIS for pneumonia, 6011 vs 9767 NIS for cellulitis, 6466 vs 8552 NIS for UTI and p value<0.05). The length of home hospitalisations was shorter for pneumonia and cellulitis (5.01 vs 6.05 days, p value 0.001 and 5.3 vs 6.1 days, p value<0.001, respectively). Likewise, for pneumonia and cellulitis, home-hospitalised patients had fewer ED referrals 30 days after discharge (13.7% vs 24%, p value<0.001 and 13.5% vs 19.8%, p value 0.002, respectively). No differences were found in recurrent hospitalisation and mortality 7 and 30 days after discharge. Conclusions Primary care physicians should consider home hospitalisation for these diagnoses as an alternative to traditional hospitalisation. Policymakers should encourage Primary care physicians to use home hospitalisation, as it has financial advantages and better health outcomes.

12 December 2023 in Healthcare
Verified
Journal Article
Open access
PDF file
BCBar Cohen
Bar Cohen
SDShirley Shapiro Ben David
Shirley Shapiro Ben David
DRDaniella Rahamim-Cohen
Daniella Rahamim-Cohen
ANAfif Nakhleh
Afif Nakhleh
ASArnon Shahar
Arnon Shahar
LALimor Adler
Limor Adler
Introduction: Correlations between SARS-CoV-2 and bacterial infections have mainly been studied in hospitals, and these studies have shown that such interactions may be lethal for many. In the context of community flora, less is known of the trends and consequences of viral infections relative to subsequent bacterial infections. Purpose: This study aims to explore the prevalence and characteristics of bacterial infections in the three months following SARS-CoV-2 infections, in a community, real-world setting. Methods: In this retrospective cohort study, we compared patients who completed a polymerase chain reaction (PCR) test or an antigen test for SARS-CoV-2 during January 2022, the peak of the Omicron wave, and examined bacterial infections following the test. We searched these cases for diagnoses of the following four bacterial infections for three months following the test: Group A Streptococcus (GAS) pharyngitis, pneumonia, cellulitis, and urinary tract infections (UTI). Results: During January 2022, 267,931 patients tested positive and 261,909 tested negative for SARS-CoV-2. Test-positive compared to test-negative patients were significantly younger (42.5 years old vs. 48.5 years old, p < 0.001), smoked less, and had fewer comorbidities (including ischemic heart disease, diabetes mellitus, hypertension, chronic obstructive pulmonary disease, and chronic renal failure). In the multivariable analysis, test-positive patients had an increased risk for GAS pharyngitis (adjusted odds ratio [aOR] = 1.25, 95% CI 1.14–1.38, p-value < 0.001) and pneumonia (aOR = 1.25, 95% CI 1.15–1.35, p-value < 0.001), a trend towards an increased prevalence of UTI (aOR = 1.05, 95% CI 0.99–1.12, p-value = 0.092), and lower risk for cellulitis (aOR = 0.92, 95% CI 0.86–0.99, p-value < 0.05). Conclusions: A history of SARS-CoV-2 infection in the past three months increased susceptibility to respiratory tract bacterial infections and the prevalence of UTI.

19 November 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
OLOri Liran
Ori Liran
SVShiraz Vered
Shiraz Vered
BCBar Cohen
Bar Cohen
SDShirley Shapiro Ben David
Shirley Shapiro Ben David
ANAfif Nakhleh
Afif Nakhleh
LALimor Adler
Limor Adler
Background: Hair loss is a common complaint, especially in the primary care setting. Despite conflicting results in previous studies regarding the role of zinc in hair loss, zinc levels are being widely tested as part of an initial laboratory investigation for hair loss. Objectives: We aimed to investigate whether lower zinc levels were associated with patients’ complaints of hair loss. Methods: In this retrospective cross-sectional study, we collected data on the zinc levels of patients diagnosed with hair loss who underwent a zinc level test after their diagnosis. The zinc levels of these patients were compared to those of a control group, which included patients who were also investigated for zinc levels for reasons other than hair loss. Results: Between 2000 and 2020, 23,975 eligible patients were included in this study. Among these patients, 9.5% (N = 2279) had a diagnosis of hair loss and a median zinc level of 96 µg/dL (84.0–110.0), compared to 99 µg/dL (85.0–115.0) in the control group (p < 0.001). Conclusions: This cross-sectional study investigated the relationship between zinc levels and complaints of hair loss. While we do report lower zinc levels in those with hair loss complaints, this change is minor and lacks clinical significance. As the standard today, we suggest that zinc levels should not be obtained as a laboratory test when investigating hair loss. Further studies on the efficacy of zinc supplements in hair loss could elucidate the clinical relevance of zinc in hair loss conditions.